Author Question: In the opening stanza to what things does the speaker compare the effectof the nightingales song? ... (Read 61 times)

james

  • Hero Member
  • *****
  • Posts: 573
In the opening stanza to what things does the speaker compare the effectof the nightingales song?
 
  What will be an ideal response?

Question 2

How could the nightingale singing in the poem be the same voice heard inthe ancient world? What point is Keats making about the permanence of nature?
 
  What will be an ideal response?



rekilledagain

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1


  • He compares the effect of the songwhich, he says, makes his heart ache and fills him with a drowsy numbnessto drinking hemlock or some other opiate. The speaker describes the song as taking him Lethe-wards, which is to suggest that the song helps him forget lifes sorrows. The seemingly magical nature of this process is underscored by his comparison of the bird to a Dryad a wood nymph out of Greek mythology.



Answer to Question 2


  • All music, all beauty, are part of undying nature. Nature, for Keats, is eternal; the bird is not a mortal creature who will die just as he will die, but is part of a natural world that knows no death.




Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library